financetom
MMSI
financetom
/
Healthcare
/
MMSI
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Merit Medical Systems, Inc.MMSI
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
5.33B
Revenue (ttm)
1.36B
Net Income (ttm)
120.36M
Shares Out
59.07M
EPS (ttm)
2.03
PE Ratio
44.36
Forward PE
24.68
Dividend
n/a
Ex-Dividend Date
n/a
Volume
234,274
Open
90.95
Previous Close
91.54
Day's Range
88.49 - 91.85
52-Week Range
70.70 - 111.45
Beta
0.85
Analysts
Buy
Price Target
114.33 (+26.75%)
Earnings Date
Apr 24, 2025
Description >

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy.

It operates in two segments, Cardiovascular and Endoscopy. The company provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.

It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems.

In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures.

It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally.

The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Latest News >
--Netflix, FIFA Sign Broadcast Deal for Women's World Cup for 2027, 2031
--Netflix, FIFA Sign Broadcast Deal for Women's World Cup for 2027, 2031
Dec 20, 2024
10:50 AM EST, 12/20/2024 (MT Newswires) -- Price: 904.23, Change: +2.19, Percent Change: +0.24 ...
Playtika, International Game Technology Partner to Bring Slots to Social Casino Games
Playtika, International Game Technology Partner to Bring Slots to Social Casino Games
Dec 20, 2024
10:50 AM EST, 12/20/2024 (MT Newswires) -- Playtika Holding ( PLTK ) said Friday it formed a partnership to bring some of International Game Technology's ( IGT ) slot themes to Playtika's ( PLTK ) social casino games. IGT slot titles will appear in Playtika's ( PLTK ) Slotomania, Caesars Slots, and House of Fun beginning this month and heading...
Eshallgo Gets Equity Financing of up to $20 Million From CS Fund
Eshallgo Gets Equity Financing of up to $20 Million From CS Fund
Dec 20, 2024
10:46 AM EST, 12/20/2024 (MT Newswires) -- Eshallgo ( EHGO ) is set to receive up to $20 million in equity investment in tranches from CS Asia Opportunities Master Fund, the companies said Friday. Under their securities purchase agreement, CS Fund will buy up to about 4.2 million shares of Eshallgo ( EHGO ) at $4.80 per share in tranches,...
Vanda Pharmaceuticals' Prospective Treatment for Blood Cancer Receives US FDA's Orphan Drug Designation
Vanda Pharmaceuticals' Prospective Treatment for Blood Cancer Receives US FDA's Orphan Drug Designation
Dec 20, 2024
10:47 AM EST, 12/20/2024 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) said Friday morning that the US Food and Drug Administration has designated the company's VGT-1849A product candidate as an orphan drug to treat polycythemia vera, a rare form of hematologic malignancy affecting about one in every 2,000 people in the country. The FDA uses orphan drug designation to...
Copyright 2023-2025 - www.financetom.com All Rights Reserved